Increase of IL-10+-expressing CD19-B220+CD5+CD1d- and CD19-B220+CD138+ cell subsets in the liver correlates with HCC progression in B-cell-deficient μMT mice. This evidence concerns the gene CD5 and hepatocellular carcinoma.